Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1981;63:102-109

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leier, C. B.
Right arrow Articles by Unverferth, D. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leier, C. B.
Right arrow Articles by Unverferth, D. V.

Circulation, Vol 63, 102-109, Copyright © 1981 by American Heart Association


ARTICLES

Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination

CB Leier, RD Magorien, CE Desch, MJ Thompson and DV Unverferth

Central and regional hemodynamic studies were performed before and after the oral administration of 75 mg of hydralazine and/or 20 mg of isosorbide dinitrate in 15 patients with low-output congestive heart failure. Hydralazine increased mean cardiac output 17-25%, mean renal blood flow 19%, and limb blood flow 17% (all p < 0.05). Mean hepatic blood flow did not change significantly with hydralazine. Except for a small increase in cardiac output (6%, p < 0.05) at 30 minutes, isosorbide dinitrate did not significantly alter central, renal, hepatic or limb blood flow. Combining isosorbide dinitrate and hydralazine effected similar increases in cardiac output (17-24%, p < 0.05), renal (17%, p < 0.05) and limb (20%, p < 0.05) blood flow as those elicited by hydralazine alone. The combination did not significantly alter mean hepatic blood flow. Hydralazine, alone or combined with isosorbide dinitrate, increases renal and limb blood flow in congestive heart failure in proportion to the augmented cardiac output; isosorbide dinitrate alone does not alter blood flow to these regions. Neither drug (or combination) changes hepatic blood flow in this clinical setting.


This article has been cited by other articles:


Home page
CirculationHome page
C. C. Lang, G. H. Rayos, D. B. Chomsky, A. J. J. Wood, and J. R. Wilson
Effect of Sympathoinhibition on Exercise Performance in Patients With Heart Failure
Circulation, July 1, 1997; 96(1): 238 - 245.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. A. Bauer, T. Nolan, and H.-L. Fung
Vascular and Hemodynamic Differences between Organic Nitrates and Nitrites
J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 326 - 331.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
J.-H. Ren, D. V. Unverferth, R. D. Magorien, and C. V. Leier
Postural Influences on the Hemodynamic Responses to Vasodilating Drugs in Congestive Heart Failure
Arch Intern Med, April 1, 1985; 145(4): 641 - 644.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
Y. Seino, J. K. Vyden, H. B. Rose, T. Takano, K. Obayashi, H. Hayakawa, and E. Kimura
Unloading Effects of Molsidomine on Peripheral Circulation and Cardiac Hemodynamics in Patients with Acute Myocardial Infarction
Angiology, August 1, 1983; 34(8): 535 - 545.
[Abstract] [PDF]